GLP1R and obesity due to melanocortin 4 receptor deficiency: Increasing evidence of efficacy and safety of GLP-1 RAs may encourage health care professionals to recognize that obesity is now a treatable serious chronic disease and motivate patients to re‐engage with weight loss when previous attempts have been ineffective or unsustainable.